Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioxyne Limited (AU:BXN)
ASX:BXN
Bioxyne Limited (BXN) Share Price & Analysis
1 Followers
BXN Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bioxyne Limited News
PremiumCompany Announcements
Bioxyne Partners for Psilocybin Clinical Trials
PremiumCompany Announcements
Bioxyne Forges Alliance for Psilocybin TherapiesPremiumCompany Announcements
Bioxyne Shareholders Show Confidence in Growth
PremiumCompany Announcements
Bioxyne Limited Reports Promising Quarter
PremiumCompany Announcements
Bioxyne Limited Announces Successful Capital Raise
PremiumCompany Announcements
Bioxyne Limited Aims for ASX QuotationOptions Prices
Currently, No data available
---
Ownership Overview
37.01% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
62.99% Public Companies and
Individual Investors
BXN FAQ
What was Bioxyne Limited’s price range in the past 12 months?
Currently, no data Available
What is Bioxyne Limited’s market cap?
Currently, no data Available
When is Bioxyne Limited’s upcoming earnings report date?
Bioxyne Limited’s upcoming earnings report date is Aug 28, 2024 which is in 36 days.
How were Bioxyne Limited’s earnings last quarter?
Bioxyne Limited released its earnings results on Feb 29, 2024. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
Is Bioxyne Limited overvalued?
According to Wall Street analysts Bioxyne Limited’s price is currently Overvalued.
Does Bioxyne Limited pay dividends?
Bioxyne Limited does not currently pay dividends.
What is Bioxyne Limited’s EPS estimate?
Bioxyne Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioxyne Limited have?
Bioxyne Limited has 2,046,645,400 shares outstanding.
What happened to Bioxyne Limited’s price movement after its last earnings report?
Bioxyne Limited reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Bioxyne Limited?
Currently, no hedge funds are holding shares in AU:BXN
---
Bioxyne Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-417.04%
Trailing 12-Months
Asset Growth
0.45%
Trailing 12-Months
Company Description
Bioxyne Limited
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Progastrim and proTract for Atopic Dermatitis. It operates in two segments: wholesale sales and direct sales. The majority of the revenue is generated from Wholesale sales in the United States and Asia.
---
---